Larissa Mooney, M.D.

Titles

Health Sciences Assistant Clinical Professor, Psychiatry and Biobehavioral Sciences

Contact Information

Email
lmooney@mednet.ucla.edu
Phone
Work Phone Number: (310) 825-5938
Address

Mailing Address:

UCLA Psych and Behavor Sciences
BOX 956913, 1640 S Sepulveda Blvd, Ste 120; 300MP #2200
Los Angeles, CA 90095
UNITED STATES

Biography

Dr. Larissa Mooney is a board certified addiction psychiatrist and Associate Clinical Professor of Psychiatry at the University of California, Los Angeles (UCLA).  She is the Director of the UCLA Addiction Psychiatry Clinic and Chief of the Greater Los Angeles Veterans Affairs Substance Use Disorders Section, where she supervises psychiatrists in training in the clinical management of addictive and mental health disorders.  Dr. Mooney is the Vice President of the American Academy of Addiction Psychiatry (AAAP) and a Fellow of the American Psychiatric Association (APA) and the American Society of Addiction Medicine (ASAM).  Dr. Mooney has conducted research at UCLA Integrated Substance Abuse Programs on pharmacological and behavioral treatment interventions for addictive disorders. She is a Co-PI of the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network. She has current funding from NIDA to study functional outcomes in cannabis users and treatment interventions for opioid use disorder and stimulant use disorder.

Publications

A selected list of publications:

Liao Jung-Yu, Mooney Larissa J, Zhu Yuhui, Valdez Jonathan, Yoo Caroline, Hser Yih-Ing   Relationships between marijuana use, severity of marijuana-related problems, and health-related quality of life Psychiatry research, 2019; .
Hser Yih-Ing, Saxon Andrew J, Mooney Larissa J, Miotto Karen, Zhu Yuhui, Yoo Caroline K, Liang Di, Huang David, Bell Douglas S   Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder Journal of addiction medicine, 2019; 13(1): 41-46.
Walker Robrina, Hillhouse Maureen, Perrochet Brian, Sparenborg Steven, Mooney Larissa, Ling Walter   Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability Journal of addiction medicine, 2019; .
Zhu Yuhui, Evans Elizabeth A, Mooney Larissa J, Saxon Andrew J, Kelleghan Annamarie, Yoo Caroline, Hser Yih-Ing   Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2018; 13(4): 488-497.
Mooney Larissa J, Zhu Yuhui, Yoo Caroline, Valdez Jonathan, Moino Kevin, Liao Jung-Yu, Hser Yih-Ing   Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2018; 13(4): 479-487.
Hser Yih-Ing, Mooney Larissa J, Huang David, Zhu Yuhui, Tomko Rachel L, McClure Erin, Chou Chih-Ping, Gray Kevin M   Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life Journal of substance abuse treatment, 2017; 81(4): 53-58.
Gray Kevin M, Sonne Susan C, McClure Erin A, Ghitza Udi E, Matthews Abigail G, McRae-Clark Aimee L, Carroll Kathleen M, Potter Jennifer S, Wiest Katharina, Mooney Larissa J, Hasson Albert, Walsh Sharon L, Lofwall Michelle R, Babalonis Shanna, Lindblad Robert W, Sparenborg Steven, Wahle Aimee, King Jacqueline S, Baker Nathaniel L, Tomko Rachel L, Haynes Louise F, Vandrey Ryan G, Levin Frances R   A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults Drug and alcohol dependence, 2017; 177(4): 249-257.
Hser Yih-Ing, Mooney Larissa J, Saxon Andrew J, Miotto Karen, Bell Douglas S, Huang David   Chronic pain among patients with opioid use disorder: Results from electronic health records data Journal of substance abuse treatment, 2017; 77(4): 26-30.
Glasner-Edwards Suzette, Mooney Larissa J, Ang Alfonso, Garneau Hélène Chokron, Hartwell Emily, Brecht Mary-Lynn, Rawson Richard A   Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial Mindfulness, 2017; 8(1): 126-135.
Ling Walter, Hillhouse Maureen P, Saxon Andrew J, Mooney Larissa J, Thomas Christie M, Ang Alfonso, Matthews Abigail G, Hasson Albert, Annon Jeffrey, Sparenborg Steve, Liu David S, McCormack Jennifer, Church Sarah, Swafford William, Drexler Karen, Schuman Carolyn, Ross Stephen, Wiest Katharina, Korthuis P Todd, Lawson William, Brigham Gregory S, Knox Patricia C, Dawes Michael, Rotrosen John   Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study Addiction (Abingdon, England), 2016; 111(8): 1416-27.
Mooney Larissa J, Hillhouse Maureen P, Thomas Christie, Ang Alfonso, Sharma Gaurav, Terry Garth, Chang Linda, Walker Robrina, Trivedi Madhukar, Croteau David, Sparenborg Steven, Ling Walter   Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder Journal of addiction medicine, 2016; 10(4): 236-43.
Robertson Chelsea L, Ishibashi Kenji, Chudzynski Joy, Mooney Larissa J, Rawson Richard A, Dolezal Brett A, Cooper Christopher B, Brown Amira K, Mandelkern Mark A, London Edythe D   Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016; 41(6): 1629-36.
Rawson Richard A, Chudzynski Joy, Mooney Larissa, Gonzales Rachel, Ang Alfonso, Dickerson Daniel, Penate Jose, Salem Bilal A, Dolezal Brett, Cooper Christopher B   Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care Drug and alcohol dependence, 2015; 156(6): 21-28.
Rawson Richard A, Chudzynski Joy, Gonzales Rachel, Mooney Larissa, Dickerson Daniel, Ang Alfonso, Dolezal Brett, Cooper Christopher B   The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting Journal of substance abuse treatment, 2015; 57(7): 36-40.
Jacobs Petra, Ang Alfonso, Hillhouse Maureen P, Saxon Andrew J, Nielsen Suzanne, Wakim Paul G, Mai Barbara E, Mooney Larissa J, S Potter Jennifer, Blaine Jack D   Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories The American journal on addictions, 2015; 24(7): 667-75.
Haglund Margaret, Ang Alfonso, Mooney Larissa, Gonzales Rachel, Chudzynski Joy, Cooper Christopher B, Dolezal Brett A, Gitlin Michael, Rawson Richard A   Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention The American journal on addictions, 2015; 24(3): 246-51.
Nielsen Suzanne, Hillhouse Maureen, Mooney Larissa, Ang Alfonso, Ling Walter   Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users Journal of substance abuse treatment, 2015; 48(1): 70-6.
Glasner-Edwards Suzette, Mooney Larissa J   Methamphetamine psychosis: epidemiology and management CNS drugs, 2014; 28(12): 1115-26.
McClure Erin A, Sonne Susan C, Winhusen Theresa, Carroll Kathleen M, Ghitza Udi E, McRae-Clark Aimee L, Matthews Abigail G, Sharma Gaurav, Van Veldhuisen Paul, Vandrey Ryan G, Levin Frances R, Weiss Roger D, Lindblad Robert, Allen Colleen, Mooney Larissa J, Haynes Louise, Brigham Gregory S, Sparenborg Steve, Hasson Albert L, Gray Kevin M   Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network Contemporary clinical trials, 2014; 39(2): 211-23.
Ling Walter, Chang Linda, Hillhouse Maureen, Ang Alfonso, Striebel Joan, Jenkins Jessica, Hernandez Jasmin, Olaer Mary, Mooney Larissa, Reed Susan, Fukaya Erin, Kogachi Shannon, Alicata Daniel, Holmes Nataliya, Esagoff Asher   Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder Addiction (Abingdon, England), 2014; 109(9): 1489-500.
Nielsen Suzanne, Hillhouse Maureen, Weiss Roger D, Mooney Larissa, Sharpe Potter Jennifer, Lee Joshua, Gourevitch Marc N, Ling Walter   The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample The American journal on addictions, 2014; 23(4): 343-8.
Dolezal Brett Andrew, Chudzynski Joy, Dickerson Daniel, Mooney Larissa, Rawson Richard A, Garfinkel Alan, Cooper Christopher B   Exercise training improves heart rate variability after methamphetamine dependency Medicine and science in sports and exercise, 2014; 46(6): 1057-66.
Mooney Larissa J, Cooper Christopher, London Edythe D, Chudzynski Joy, Dolezal Brett, Dickerson Daniel, Brecht Mary-Lynn, Peñate Jose, Rawson Richard A   Exercise for methamphetamine dependence: rationale, design, and methodology Contemporary clinical trials, 2014; 37(1): 139-47.
Mooney Larissa J, Nielsen Suzanne, Saxon Andrew, Hillhouse Maureen, Thomas Christie, Hasson Albert, Stablein Don, McCormack Jennifer, Lindblad Robert, Ling Walter   Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology Contemporary clinical trials, 2013; 34(2): 196-204.
Dolezal Brett A, Chudzynski Joy, Storer Thomas W, Abrazado Marlon, Penate Jose, Mooney Larissa, Dickerson Daniel, Rawson Richard A, Cooper Christopher B   Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment Journal of addiction medicine, 2013; 7(2): 122-8.
Ling Walter, Mooney Larissa, Wu Li-Tzy   Advances in opioid antagonist treatment for opioid addiction The Psychiatric clinics of North America, 2012; 35(2): 297-308.
Nielsen Suzanne, Hillhouse Maureen, Mooney Larissa, Fahey Jacqueline, Ling Walter   Comparing buprenorphine induction experience with heroin and prescription opioid users Journal of substance abuse treatment, 2012; 35(2): .
Glasner-Edwards Suzette, Mooney Larissa J, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Rawson Richard   Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment Eating disorders, 2011; 19(3): 259-69.
Ling Walter, Mooney Larissa, Hillhouse Maureen   Prescription opioid abuse, pain and addiction: clinical issues and implications Drug and alcohol review, 2011; 30(3): 300-5.
Glasner-Edwards Suzette, Mooney Larissa J, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Rawson Richard, Rawson Richard   Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 2011; 19(5): 385-90.
Gonzales Rachel, Brecht Mary-Lynn, Mooney Larissa, Rawson Richard A   Prescription and over-the-counter drug treatment admissions to the California public treatment system Journal of substance abuse treatment, 2011; 40(3): 224-9.
Ling Walter, Mooney Larissa, Zhao Min, Nielsen Suzanne, Torrington Matthew, Miotto Karen   Selective review and commentary on emerging pharmacotherapies for opioid addiction Substance abuse and rehabilitation, 2011; 2(2): 181-8.
Gonzales Rachel, Mooney Larissa, Rawson Richard A   The methamphetamine problem in the United States Annual review of public health, 2010; 31(3): 385-98.
Shetty Vivek, Mooney Larissa J, Zigler Corwin M, Belin Thomas R, Murphy Debra, Rawson Richard   The relationship between methamphetamine use and increased dental disease Journal of the American Dental Association (1939), 2010; 141(3): 307-18.
Glasner-Edwards Suzette, Mooney Larissa J, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Rawson Richard A, Rawson Richard A   Psychopathology in methamphetamine-dependent adults 3 years after treatment Drug and alcohol review, 2010; 29(1): 12-20.
Mooney Larissa J, Glasner-Edwards Suzette, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Hunter Jeremy, Haning William, Colescott Paula, Ling Walter, Rawson Richard   Health conditions in methamphetamine-dependent adults 3 years after treatment Journal of addiction medicine, 2009; 3(3): 155-63.
Glasner-Edwards Suzette, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Mooney Larissa J, Rawson Richard, Rawson Richard   Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up The Journal of nervous and mental disease, 2009; 197(4): 225-31.
Glasner-Edwards Suzette, Mooney Larissa J, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Rawson Richard, Rawson Richard   Clinical course and outcomes of methamphetamine-dependent adults with psychosis Journal of substance abuse treatment, 2008; 35(4): 445-50.
Gonzales Rachel, Marinelli-Casey Patricia, Hillhouse Maureen, Hunter Jeremy, Rawson Richard A, Mooney Larissa, Ang Alfonso   Hepatitis A and B infection among methamphetamine-dependent users Journal of substance abuse treatment, 2008; 35(3): 351-2.
Glasner-Edwards Suzette, Mooney Larissa J, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Rawson Richard, Rawson Richard   Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 2008; 17(2): 99-102.
Glasner-Edwards Suzette, Mooney Larissa J, Marinelli-Casey Patricia, Hillhouse Maureen, Ang Alfonso, Rawson Richard, Rawson Richard   Risk factors for suicide attempts in methamphetamine-dependent patients The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 2008; 17(1): 24-7.